Alternative diabetes medications or weight management strategies exist, and your healthcare team can discuss options that balance metabolic benefits against tolerability
As GLP-1 spending continues to skyrocket, understanding and addressing behavioral and systemic barriers is essential for sustainable market growth
Sultan As America gets thinner with the help of GLP-1 medications like Ozempic, Wegovy, and Mounjaro, a new challenge is emerging: how to manage the side effects that come with rapid weight loss
Schlogl H, Kabisch S, Horstmann A, Lohmann G, Muller K, Lepsien J, et al
(Wegovy, Mounjaro & the New Pill, 2026) Updated 22/06/26 Based on the available clinical evidence, Mounjaro (tirzepatide) and Wegovy (semaglutide) are both well tolerated, but most people find Mounjaro causes fewer gastrointestinal side effects at comparable doses, with lower rates of nausea and a higher likelihood of completing treatment